STOCK TITAN

AI/ML Innovations Inc. Announces Update to Closing of Financing

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has updated its previous announcement regarding a non-brokered private placement. The Company accepted subscriptions for 4,867,748 units at a price of $0.06 per unit, bringing gross proceeds to $292,064.88, lower than the earlier stated 5,086,498 units. AI/ML continues to focus on investments in artificial intelligence (AI) and machine learning (ML), particularly in digital health and wellbeing sectors. The Company holds strategic partnerships, including a 70% ownership in Health Gauge and AI Rx Inc., which aim to enhance healthcare solutions.

Positive
  • Raised gross proceeds of $292,064.88 from the placement.
  • Strategic partnerships with Health Gauge and AI Rx Inc. support growth in AI and ML health sectors.
Negative
  • Lower acceptance of units (4,867,748 vs. previous 5,086,498) may indicate weaker investor interest.

TORONTO, ON / ACCESSWIRE / March 15, 2023 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is providing an update to its previous announcement on the closing a non-brokered private placement. The Company advises that it accepted subscriptions for 4,867,748 units at a price of $0.06 per unit, not 5,086,498 units as previously announced. The gross proceeds totaled $292,064.88.

For more information, please contact:

Blake Fallis (778) 405-0882 or info@aiml-innovations.com

For detailed information please see the Company's website at https://aiml-innovations.com/ or the

Company's filed documents at www.sedar.com.

About AI/ML Innovations Inc.

AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (70% owned by AIML), Tech2Heal (up to 22% ownership rights, with 9.44% currently owned), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. The Company's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Certain statements in this news release are "forward-looking statements", which reflect management's expectations regarding the timing of the filing of the Required Documents. All statements other than statements of historical fact contained in this news release are forward looking statements. Such forward-looking statements involve risks and uncertainties, as they reflect management's current beliefs and are based on information currently available to management. Actual results may differ materially from those anticipated in the statements made. The forward-looking statements are expressly qualified in their entirety by this cautionary statement. The forward-looking statements are made as of the date of this news release and AI/ML assumes no obligation to update or revise them to reflect new events or circumstances except as expressly required by applicable securities law. Further information regarding the uncertainties and risks can be found in the disclosure documents filed by AI/ML with the securities regulatory authorities, available at www.sedar.com.

SOURCE: AI/ML Innovations Inc.



View source version on accesswire.com:
https://www.accesswire.com/744099/AIML-Innovations-Inc-Announces-Update-to-Closing-of-Financing

FAQ

What were the gross proceeds from AI/ML Innovations' latest private placement?

The gross proceeds totaled $292,064.88.

How many units did AI/ML Innovations accept in its recent financing?

AI/ML Innovations accepted subscriptions for 4,867,748 units.

What is the price per unit in AI/ML Innovations' recent financing?

The price per unit was $0.06.

What strategic partnerships does AI/ML Innovations have?

AI/ML has partnerships with Health Gauge and AI Rx Inc., among others.

What is the symbol for AI/ML Innovations on the OTCQB market?

The symbol for AI/ML Innovations on the OTCQB market is AIMLF.

AI / ML INNOVATIONS INC

OTC:AIMLF

AIMLF Rankings

AIMLF Latest News

AIMLF Stock Data

8.33M
112.14M
30.49%
Health Information Services
Healthcare
Link
United States of America
Victoria